Furthermore, survival analysis of the TCGA datasets revealed that HNSCC patients with higher ITGAV gene expression had a significantly worse overall survival rate compared to those with lower ITGAV expression (Figure 2). The gene discussed is ITGAV; the disease is head and neck squamous cell carcinoma.